Abstract
Background: The problem of poor immunogenicity of new generation vaccines has generated the need for more effective and safe adjuvants for inducing a seroprotective immune response.
Objective and Method: The plant-based immunoadjuvants have the potential to promote an optimized immune response and are promising candidate adjuvants for novel vaccine development. There are many natural compounds, which exhibit vaccine adjuvant activity. However, safety and hemolytic toxicity remain a problem. Research in the last four decades shows that plant extracts can be screened for isolating the least toxic adjuvant. Plant-based adjuvants with their superior immunostimulatory property could provide us with an effective alternative to conventional adjuvants.
Conclusion: The present paper enumerates the plant-based immunoadjuvant which has shown remarkable immunostimulatory properties.
Keywords: Haemolytic, immunoadjuvant, ovalbumin, polysaccharide, saponins, splenocyte.
Current Traditional Medicine
Title:Plant-based Adjuvant in Vaccine Immunogenicity: A Review
Volume: 4 Issue: 3
Author(s): P.K. Lakshmi, Shweta Kumar, Sulakshhna Pawar, M.S. Sudheesh and Rajesh Singh Pawar*
Affiliation:
- Truba Institute of Pharmacy, Karod-Gandhi Nagar, By Pass Road, Bhopal, 462038,India
Keywords: Haemolytic, immunoadjuvant, ovalbumin, polysaccharide, saponins, splenocyte.
Abstract: Background: The problem of poor immunogenicity of new generation vaccines has generated the need for more effective and safe adjuvants for inducing a seroprotective immune response.
Objective and Method: The plant-based immunoadjuvants have the potential to promote an optimized immune response and are promising candidate adjuvants for novel vaccine development. There are many natural compounds, which exhibit vaccine adjuvant activity. However, safety and hemolytic toxicity remain a problem. Research in the last four decades shows that plant extracts can be screened for isolating the least toxic adjuvant. Plant-based adjuvants with their superior immunostimulatory property could provide us with an effective alternative to conventional adjuvants.
Conclusion: The present paper enumerates the plant-based immunoadjuvant which has shown remarkable immunostimulatory properties.
Export Options
About this article
Cite this article as:
Lakshmi P.K. , Kumar Shweta , Pawar Sulakshhna , Sudheesh M.S. and Pawar Singh Rajesh *, Plant-based Adjuvant in Vaccine Immunogenicity: A Review, Current Traditional Medicine 2018; 4 (3) . https://dx.doi.org/10.2174/2215083804666180830142648
DOI https://dx.doi.org/10.2174/2215083804666180830142648 |
Print ISSN 2215-0838 |
Publisher Name Bentham Science Publisher |
Online ISSN 2215-0846 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Heparanase as a Target in Cancer Therapy
Current Cancer Drug Targets Approaches for Imaging the Diabetic Pancreas: First Results
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Phytochemicals Resveratrol and Sulforaphane as Potential Agents for Enhancing the Anti-Tumor Activities of Conventional Cancer Therapies
Current Pharmaceutical Biotechnology Natural Products Derived from Traditional Chinese Medicine as Novel Inhibitors of the Epidermal Growth Factor Receptor
Combinatorial Chemistry & High Throughput Screening The Role of 3D Pharmacophore Mapping Based Virtual Screening for Identification of Novel Anticancer Agents: An Overview
Current Topics in Medicinal Chemistry The Inverse Relationship Between Cancer and Alzheimer's Disease: A Possible Mechanism
Current Alzheimer Research Combined Modality Treatment of Limited Stage Small Cell Carcinoma of the Lung
Reviews on Recent Clinical Trials ErbB Targeted Drugs and Angiogenesis
Current Vascular Pharmacology The Pathobiology of Endothelin-1 in Vein Graft Disease: Are ETA Receptor Antagonists the Solution to Prevent Vein Graft Failure?
Current Vascular Pharmacology Immunotherapy in Gastric Carcinoma: Current Status and Future Perspectives
Clinical Cancer Drugs Cellular Therapy for Ovarian Cancer: Experimental and Clinical Perspectives
Current Medicinal Chemistry Cancer Prevention and Therapy in a Preclinical Mouse Model: Impact of FHIT Viruses
Current Gene Therapy Evolution of Exenatide as a Diabetes Therapeutic
Current Diabetes Reviews Chronopharmacology and Antimicrobial Therapeutics
Current Clinical Pharmacology Interactions of Iron Oxide Nanoparticles with the Immune System: Challenges and Opportunities for their Use in Nano-oncology
Current Pharmaceutical Design Immunology Behind Tumors: A Mini Review
Current Cancer Therapy Reviews Tumor Stroma Manipulation By MSC
Current Drug Targets Nano Drug Delivery in Treatment of Oral Cancer, A Review of the Literature
Current Drug Targets Interrelationships of Circulating Tumor Cells with Metastasis and Thrombosis: Role of MicroRNAs
Current Pharmaceutical Design Tumor Immune Escape Mechanisms that Operate During Metastasis
Current Pharmaceutical Biotechnology